Targeting AFP-RARβ complex formation: a potential strategy for treating AFP-positive hepatocellular carcinoma

Banjan, Bhavya; Vishwakarma, Riya; Ramakrishnan, Krishnapriya; Dev, Radul R.; Kalath, Haritha; Kumar, Pankaj; Soman, Sowmya; Raju, Rajesh; Revikumar, Amjesh; Rehman, Niyas; Abhinand, Chandran S.

doi:10.1007/s11030-024-10915-8

Mol Divers

2024

DOI: 10.1007/s11030-024-10915-8

|View full text |Cite

Targeting AFP-RARβ complex formation: a potential strategy for treating AFP-positive hepatocellular carcinoma

Bhavya Banjan,

Riya Vishwakarma,

Krishnapriya Ramakrishnan

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 82 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

In-silico studies on evaluating the liver-protective effectiveness of a polyherbal formulation in preventing hepatocellular carcinoma progression

Kalath,

Vishwakarma,

Banjan

et al. 2024

In Silico Pharmacol.

View full text Add to dashboard Cite

In-silico studies on evaluating the liver-protective effectiveness of a polyherbal formulation in preventing hepatocellular carcinoma progression

Kalath,

Vishwakarma,

Banjan

et al. 2024

In Silico Pharmacol.

View full text Add to dashboard Cite

A Network Map of Intracellular Alpha‐Fetoprotein Signalling in Hepatocellular Carcinoma

Ramakrishnan,

Sanjeev,

Rehman

et al. 2024

Journal of Viral Hepatitis

View full text Add to dashboard Cite

Alpha fetoprotein (AFP) is a glycoprotein of foetal origin belonging to the albumin protein family. Serum AFP is a long‐conceived early‐diagnostic biomarker for HCC with its elevated expression in different liver pathologies ranging from hepatitis viral infections to fibrosis, cirrhosis, and HCC. Beyond their utility as biomarkers, in support of its contribution to these clinical outcomes, the function of AFP as an immune suppressor and inducer of malignant transformation in HCC patients is well reported. Multiple reports show that AFP is secreted by hepatocytes, binds to its cognate receptor, AFP‐receptor (AFPR), and exerts its actions. However, there is only limited information available in this context. There is an urgent need to gather more insight into the AFP signalling pathway and consider it a classical intracellular signalling pathway, among others. AFP is a highly potent intracellular molecule that has the potential to bind to many interactors like PTEN, Caspase, RAR, and so on. It has been shown that cellular AFP and secreted AFP have different roles in HCC pathophysiology, and a comprehensive map of the AFP signalling pathway is warranted for further theranostic applications.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Targeting AFP-RARβ complex formation: a potential strategy for treating AFP-positive hepatocellular carcinoma

Cited by 2 publications

References 82 publications

In-silico studies on evaluating the liver-protective effectiveness of a polyherbal formulation in preventing hepatocellular carcinoma progression

In-silico studies on evaluating the liver-protective effectiveness of a polyherbal formulation in preventing hepatocellular carcinoma progression

A Network Map of Intracellular Alpha‐Fetoprotein Signalling in Hepatocellular Carcinoma

Contact Info

Product

Resources

About